Industry

Study Evaluates the Effectiveness of TherOx Supersaturated Oxygen (SSO2) Therapy in Patients Presenting with Acute Anterior Myocardial Infarction with Successful Reperfusion Compared to Standard Therapy CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that the first patient has enrolled in the AMIHOT III post-approval … [Read more…]

REIMS, France–(BUSINESS WIRE)–BCV announces a major step in the development and evaluation of steerable mechatronic guidewires for stroke treatment – the GECKO System. The first-in-human case was conducted by Michel Piotin, MD, PhD, head of Interventional neuroradiology at Foundation Rothschild Hospital in Paris, France. Worldwide each year more than 12.2 million people suffer a stroke.1 … [Read more…]

New capital will support ongoing development of their drug pipeline targeting transcriptional mechanisms in disease Arpeggio’s technology isolates a drug’s effect on entire transcriptomes and has identified new modulators of hard-to-drug proteins like transcription factors To date, Arpeggio has contracted with more than 40 pharmaceutical companies to assess the impact of diverse classes of molecules … [Read more…]

OXFORD, England–(BUSINESS WIRE)–Exscientia (Nasdaq: EXAI) today announced that Company management will participate in the following investor conferences in September: Morgan Stanley Annual Global Healthcare Conference: Date: Wednesday, September 14, 2022 Time: 3:35 p.m. BST / 10:35 a.m. EST Location: New York, New York Participants: Ben Taylor, CFO & Chief Strategy Officer and Dave Hallett, Chief … [Read more…]

Results from the study showed adults and children aged 13 and older with uncontrolled asthma using the ProAir Digihaler and its integrated system had 85.3% higher odds of improving their asthma control after three months compared with those using standard of care albuterol inhalers Physicians reported more interactions with patients on poor inhaler technique based … [Read more…]

Individuals with memory problems encouraged to learn more about study MATTHEWS, N.C.–(BUSINESS WIRE)–AMC Research is initiating a clinical trial for a promising new investigational treatment for Alzheimer’s disease (AD) in Matthews, N.C. The Phase I study will determine the safety and tolerability of a single intravenous (IV) dose and multiple IV doses of ACU193. We … [Read more…]

BOSTON–(BUSINESS WIRE)–Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the company will participate in the Morgan Stanley 20th Annual Global Healthcare Conference taking place September 12-14, 2022 in New York City. Corey McCann, M.D., Ph.D., President and CEO, will participate in a fireside … [Read more…]

More than 126 employees to ride in the company’s annual Coast 2 Coast 4 Cancer ride through towns and cities between the Oregon Coast and the New Jersey shore PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #C2C4C–Bristol Myers Squibb employees will embark on a cross-country bike ride from the coast of Oregon to honor loved ones who have been … [Read more…]

PITTSBURGH–(BUSINESS WIRE)–Carmell Therapeutics, a pioneering company in the development and commercialization of innovative Plasma-based Bioactive Materials (PBMs) to accelerate bone and soft tissue healing, today announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the “SEC”) relating to the proposed public listing of its Class … [Read more…]

CAMBRIDGE, Mass. & MONTREAL–(BUSINESS WIRE)–Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced that members of its senior management team will participate at two investor conferences in September. Details for the fireside chats are as follows: Morgan Stanley 20th Annual Global Healthcare Conference Date: Wednesday, September 14, … [Read more…]